Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/4007
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | - |
dc.contributor.author | CARETA, Mariana Figueiroa | - |
dc.contributor.author | LEITE, Claudia da Costa | - |
dc.contributor.author | CRESTA, Fernando | - |
dc.contributor.author | ALBINO, Jose | - |
dc.contributor.author | TSUNAMI, Mirian | - |
dc.contributor.author | ROMITI, Ricardo | - |
dc.date.accessioned | 2014-01-28T22:20:03Z | - |
dc.date.available | 2014-01-28T22:20:03Z | - |
dc.date.issued | 2013 | - |
dc.identifier.citation | AUTOIMMUNITY REVIEWS, v.12, n.11, p.1064-1069, 2013 | - |
dc.identifier.issn | 1568-9972 | - |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/4007 | - |
dc.description.abstract | Introduction: Scleroderma featuring rare connective tissue disease that manifests as skin sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement and localized scleroderma or morphea which classically presents benign evolution and self-limited, confined to the skin and/or underlying tissue. Recent studies show that the localized form may possibly course with involvement of internal organs and variable morbidity. This study aimed to determine the demographic characteristics, the prevalence of systemic manifestations and laboratory findings, as well as the association with autoimmune diseases, and the evolution of neurological findings, both clinical as brain MRI in patients with scleroderma of the face and its relation with the activity skin. Methods: Patients with localized scleroderma with facial involvement were evaluated and underwent neurological examination, magnetic resonance imaging and ophthalmology evaluation. After 3 years, the patients were subjected again to MRI. Results: We studied 12 patients with localized scleroderma of the face. Of this total, headache being the most frequent complaint found in 66.7% of patients, 33.3% had neurological changes possibly associated with scleroderma. As for ophthalmologic evaluation, 25% of patients showed abnormalities. The most frequent parenchymal finding was the presence of lesions with hyperintense or hypointense signal in 75% of patients, followed by ventricular asymmetry at 16.7%. Of the patients who had neurological deficits, 75% also had a change to MRI. In all patients, imaging findings after 3 years were unchanged. During this interval of 3 years, 25% of patients showed signs of activity of scleroderma. Conclusion: Patients with localized scleroderma of the face have a high prevalence of neurological and ophthalmological changes. Based on these findings, we suggest that all cases of localized scleroderma of the face should be thoroughly examined for the presence of systemic changes. | - |
dc.language.iso | eng | - |
dc.publisher | ELSEVIER SCIENCE BV | - |
dc.relation.ispartof | Autoimmunity Reviews | - |
dc.rights | restrictedAccess | - |
dc.subject | Localized scleroderma of the face | - |
dc.subject | Magnetic resonance image | - |
dc.subject | Systemic involvement | - |
dc.subject | Neurological disorders | - |
dc.subject | Ophthalmologic disorders | - |
dc.subject | Collagen's disease | - |
dc.subject.other | parry-romberg-syndrome | - |
dc.subject.other | progressive facial hemiatrophy | - |
dc.subject.other | morphea localized scleroderma | - |
dc.subject.other | en-coup | - |
dc.subject.other | linear scleroderma | - |
dc.subject.other | systemic-sclerosis | - |
dc.subject.other | hashimotos-thyroiditis | - |
dc.subject.other | neuroimaging findings | - |
dc.subject.other | follow-up | - |
dc.subject.other | sabre | - |
dc.title | Prospective study to evaluate the clinical and radiological outcome of patients with scleroderma of the face | - |
dc.type | article | - |
dc.rights.holder | Copyright ELSEVIER SCIENCE BV | - |
dc.identifier.doi | 10.1016/j.autrev.2013.05.005 | - |
dc.identifier.pmid | 23791631 | - |
dc.subject.wos | Immunology | - |
dc.type.category | review | - |
dc.type.version | publishedVersion | - |
hcfmusp.author.external | TSUNAMI, Mirian:Univ Sao Paulo, Sch Med, Dept Bioestatisc, BR-05508 Sao Paulo, Brazil | - |
hcfmusp.description.beginpage | 1064 | - |
hcfmusp.description.endpage | 1069 | - |
hcfmusp.description.issue | 11 | - |
hcfmusp.description.volume | 12 | - |
hcfmusp.origem | WOS | - |
hcfmusp.origem.id | WOS:000323872800006 | - |
hcfmusp.origem.id | 2-s2.0-84881544877 | - |
hcfmusp.publisher.city | AMSTERDAM | - |
hcfmusp.publisher.country | NETHERLANDS | - |
hcfmusp.relation.reference | Appenzeller S, 2004, NEUROLOGY, V62, P1585 | - |
hcfmusp.relation.reference | BIRDI N, 1993, ARTHRITIS RHEUM, V36, P410, DOI 10.1002/art.1780360318 | - |
hcfmusp.relation.reference | Blaszczyk M, 2003, J RHEUMATOL, V30, P1997 | - |
hcfmusp.relation.reference | Blaszczyk M, 1996, CUTIS, V58, P148 | - |
hcfmusp.relation.reference | Bonilla G, 1995, J RHEUMATOL, V22, P73 | - |
hcfmusp.relation.reference | Cardenas-Roldan J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-73 | - |
hcfmusp.relation.reference | CHAZEN EM, 1962, J PEDIATR, V60, P385, DOI 10.1016/S0022-3476(62)80064-X | - |
hcfmusp.relation.reference | Chbicheb M, 2005, REV NEUROL-FRANCE, V161, P92, DOI 10.1016/S0035-3787(05)84980-X | - |
hcfmusp.relation.reference | Chiu YE, 2012, PEDIATR DERMATOL, V29, P738, DOI 10.1111/pde.12001 | - |
hcfmusp.relation.reference | Christen-Zaech S, 2008, J AM ACAD DERMATOL, V59, P385, DOI 10.1016/j.jaad.2008.05.005 | - |
hcfmusp.relation.reference | CHRISTIANSON HB, 1956, ARCH DERMATOL, V74, P629 | - |
hcfmusp.relation.reference | Cipriani P, 2013, AUTOIMMUN REV, V12, P709, DOI 10.1016/j.autrev.2012.10.004 | - |
hcfmusp.relation.reference | DEHEN L, 1994, MEDICINE, V73, P241 | - |
hcfmusp.relation.reference | Dervis E, 2004, INT J DERMATOL, V43, P236, DOI 10.1111/j.1365-4632.2004.01973.x | - |
hcfmusp.relation.reference | Eubanks LE, 1996, INT J DERMATOL, V35, P330, DOI 10.1111/j.1365-4362.1996.tb03633.x | - |
hcfmusp.relation.reference | Fain ET, 2011, PEDIATR RHEUMATOL, V9, DOI 10.1186/1546-0096-9-18 | - |
hcfmusp.relation.reference | FENELON G, 1993, J NEUROL NEUROSUR PS, V56, P622, DOI 10.1136/jnnp.56.6.622 | - |
hcfmusp.relation.reference | Fett N, 2011, J AM ACAD DERMATOL, V64, P217, DOI 10.1016/j.jaad.2010.05.045 | - |
hcfmusp.relation.reference | Finkelstein Eve, 1995, Journal of Dermatology (Tokyo), V22, P351 | - |
hcfmusp.relation.reference | Fitzpatrick TB, 1987, DERMATOLOGY GENERAL, P1841 | - |
hcfmusp.relation.reference | Gambichler T, 2001, BMC Dermatol, V1, P9, DOI 10.1186/1471-5945-1-9 | - |
hcfmusp.relation.reference | Goldberg-Stern H, 1997, NEURORADIOLOGY, V39, P873 | - |
hcfmusp.relation.reference | Holland KE, 2006, PEDIATRICS, V117, pE132, DOI 10.1542/peds.2005-0470 | - |
hcfmusp.relation.reference | Holl-Wieden A, 2006, SCAND J RHEUMATOL, V35, P402, DOI 10.1080/03009740600556126 | - |
hcfmusp.relation.reference | JABLONSKA S, 1992, CLIN DERMATOL, V10, P407, DOI 10.1016/0738-081X(92)90087-F | - |
hcfmusp.relation.reference | Jimenez SA, 2013, AUTOIMMUN REV, DOI 10.1016/J.AUTREV.2013.04.004.[EPUB | - |
hcfmusp.relation.reference | Kister I, 2008, NEUROLOGY, V71, P1538, DOI 10.1212/01.wnl.0000334474.88923.e3 | - |
hcfmusp.relation.reference | KRAFCHIK BR, 1992, SEMIN DERMATOL, V11, P65 | - |
hcfmusp.relation.reference | Lee HJ, 2002, ACTA DERM-VENEREOL, V82, P58, DOI 10.1080/000155502753600920 | - |
hcfmusp.relation.reference | Leitenberger JJ, 2009, ARCH DERMATOL, V145, P545, DOI 10.1001/archdermatol.2009.79 | - |
hcfmusp.relation.reference | Li SC, 2012, ARTHRIT CARE RES, V64, P1175, DOI 10.1002/acr.21687 | - |
hcfmusp.relation.reference | Martin P, 2012, AUTOIMMUN REV, V11, P827, DOI 10.1016/j.autrev.2012.02.017 | - |
hcfmusp.relation.reference | Marzano AV, 2003, EUR J DERMATOL, V13, P171 | - |
hcfmusp.relation.reference | MAYORQUIN FJ, 1994, J RHEUMATOL, V21, P1955 | - |
hcfmusp.relation.reference | Mehra S, 2013, AUTOIMMUN REV, V12, P340, DOI 10.1016/j.autrev.2012.05.011 | - |
hcfmusp.relation.reference | Menascu S, 2009, PEDIATR NEUROL, V40, P321, DOI 10.1016/j.pediatrneurol.2008.11.007 | - |
hcfmusp.relation.reference | Moko SB, 2003, J CRANIO MAXILL SURG, V31, P321, DOI 10.1016/S1010-5182(03)00028-3 | - |
hcfmusp.relation.reference | Pagano M, 2011, PRINCIPIOS BIOESTATI | - |
hcfmusp.relation.reference | Peterson LS, 1997, J RHEUMATOL, V24, P73 | - |
hcfmusp.relation.reference | Ramboer K, 1997, BRIT J OPHTHALMOL, V81, P90, DOI 10.1136/bjo.81.1.90 | - |
hcfmusp.relation.reference | Rossi D, 2013, AUTOIMMUN REV, V12, P821, DOI 10.1016/j.autrev.2012.11.006 | - |
hcfmusp.relation.reference | Sommer A, 2006, J AM ACAD DERMATOL, V54, P227, DOI 10.1016/j.jaad.2005.10.020 | - |
hcfmusp.relation.reference | STANECZEK W, 1992, CLIN NEUROPATHOL, V11, P135 | - |
hcfmusp.relation.reference | Stone J, 2003, NEUROLOGY, V61, P674 | - |
hcfmusp.relation.reference | Stone J, 2001, J NEUROL NEUROSUR PS, V70, P382, DOI 10.1136/jnnp.70.3.382 | - |
hcfmusp.relation.reference | TERSTEGGE K, 1994, AM J NEURORADIOL, V15, P145 | - |
hcfmusp.relation.reference | Tollefson MM, 2007, J AM ACAD DERMATOL, V56, P157 | - |
hcfmusp.relation.reference | Tuffanelli DL, 1998, SEMIN CUTAN MED SURG, V17, P27, DOI 10.1016/S1085-5629(98)80059-X | - |
hcfmusp.relation.reference | Unterberger I, 2003, J NEUROL NEUROSUR PS, V74, P661, DOI 10.1136/jnnp.74.5.661 | - |
hcfmusp.relation.reference | Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972 | - |
hcfmusp.relation.reference | Vierra E, 1999, SEMIN CUTAN MED SURG, V18, P210, DOI 10.1016/S1085-5629(99)80019-4 | - |
hcfmusp.relation.reference | Villalta D, 2012, AUTOIMMUN REV, V12, P114, DOI 10.1016/j.autrev.2012.07.005 | - |
hcfmusp.relation.reference | Zannin ME, 2007, BRIT J OPHTHALMOL, V91, P1311, DOI 10.1136/bjo.2007.116038 | - |
hcfmusp.relation.reference | Zulian F, 2005, ARTHRITIS RHEUM, V52, P2873, DOI 10.1002/art.21264 | - |
hcfmusp.relation.reference | Zulian F, 2006, RHEUMATOLOGY, V45, P614, DOI 10.1093/rheumatology/kei251 | - |
dc.description.index | MEDLINE | - |
hcfmusp.citation.scopus | 25 | - |
hcfmusp.scopus.lastupdate | 2024-04-12 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - FM/MDR Artigos e Materiais de Revistas Científicas - HC/ICHC Artigos e Materiais de Revistas Científicas - HC/ICr Artigos e Materiais de Revistas Científicas - HC/InRad Artigos e Materiais de Revistas Científicas - LIM/33 Artigos e Materiais de Revistas Científicas - LIM/44 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_CARETA_Prospective_study_to_evaluate_the_clinical_and_radiological_2013.PDF Restricted Access | publishedVersion (English) | 623.37 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.